XML 30 R15.htm IDEA: XBRL DOCUMENT
v3.25.0.1

Selected Balance Sheet Information | 12 Months Ended
--- | ---
Dec. 31, 2024
Selected Balance Sheet Information |
Selected Balance Sheet Information | 6. Selected Balance Sheet Information PREPAID EXPENSES AND OTHER CURRENT ASSETS (in thousands): ​
​ | ​ | ​ | ​ | ​ | ​ | ​
​ |  | December 31, |  | December 31,
​ | ​ | 2024 | ​ | 2023
Prepaid manufacturing expenses | ​ | $ | 375 | ​ | $ | 491
Prepaid insurance | ​ | ​ | 374 | ​ | ​ | 496
Prepaid clinical research organizations | ​ | ​ | 365 | ​ | ​ | 1,119
Prepaid consulting, subscriptions and other expenses | ​ | ​ | 235 | ​ | ​ | 180
VAT receivable | ​ |  | 95 | ​ |  | 128
​ | ​ | ​ | ​ | ​ | ​ | ​
Total prepaid expenses and other current assets | ​ | $ | 1,444 | ​ | $ | 2,414
​ Prepaid clinical research organizations (CROs) expense is classified as a current asset. The Company makes payments to the CROs based on agreed upon terms that include payments in advance of study services. PROPERTY AND EQUIPMENT (in thousands) ​
​ | ​ | ​ | ​ | ​ | ​ | ​
​ |  | December 31, |  | December 31,
​ | ​ | 2024 | ​ | 2023
Computers and office equipment | ​ | $ | 708 | ​ | $ | 902
Other property, plant and equipment | ​ | ​ | 392 | ​ | ​ | 417
Leasehold improvements | ​ |  | 94 | ​ |  | 94
Software | ​ |  | 11 | ​ |  | 11
​ | ​ |  | 1,205 | ​ |  | 1,424
Less: accumulated depreciation and amortization | ​ |  | (935) | ​ |  | (1,002)
​ | ​ |  |  | ​ |  |
Total property and equipment, net | ​ | $ | 270 | ​ | $ | 422
​ During the years ended December 31, 2024 and 2023 the Company recognized depreciation expense of $137,000 and 135,000 respectively. ​ ACCRUED EXPENSES (in thousands) ​
​ | ​ | ​ | ​ | ​ | ​ | ​
​ |  | December 31, |  | December 31,
​ | ​ | 2024 | ​ | 2023
Accrued clinical consulting services | ​ | $ | 2,390 | ​ | $ | 1,700
Accrued manufacturing costs | ​ | ​ | 772 | ​ | ​ | 843
Accrued vendor payments | ​ | ​ | 206 | ​ | ​ | 452
​ | ​ |  |  | ​ |  |
Total accrued expenses | ​ | $ | 3,368 | ​ | $ | 2,995
​ ACCRUED EMPLOYEE BENEFITS (in thousands) ​
​ | ​ | ​ | ​ | ​ | ​ | ​
​ |  | December 31, |  | December 31,
​ | ​ | 2024 | ​ | 2023
Accrued bonus expense | ​ | $ | 870 | ​ | $ | 1,307
Accrued compensation expense | ​ |  | 187 | ​ |  | 127
Accrued vacation expense | ​ | ​ | 87 | ​ | ​ | 83
​ | ​ |  |  | ​ | ​ |
Total accrued employee benefits | ​ | $ | 1,144 | ​ | $ | 1,517
​

X
- References No definition available. + Details
Name: | tovx_BalanceSheetInformationAbstract
Namespace Prefix: | tovx_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for supplemental balance sheet disclosures, including descriptions and amounts for assets, liabilities, and equity. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 210 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/210/tableOfContent + Details
Name: | us-gaap_SupplementalBalanceSheetDisclosuresTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration